Story perspectives

FDA Lifts Black Box Warnings on Menopause Hormone Therapy

11/10/2025

36 2

Summary

Story summary

The U.S. Food and Drug Administration (FDA) announced on November 10, 2025 it will remove black box warnings from menopause hormone therapy, increasing accessibility.
The change is expected to increase treatment accessibility.
FDA Commissioner Dr. Marty Makary criticized the warnings as a "fear machine" deterring women from care.
Experts say updated research shows substantial benefits, especially when started before age 60.
The move aligns with rising U.S. legislative efforts to improve menopause care and remove barriers for millions.

1 of 1

Story summary

The U.S. Food and Drug Administration (FDA) announced on November 10, 2025 it will remove black box warnings from menopause hormone therapy, increasing accessibility.
The change is expected to increase treatment accessibility.
FDA Commissioner Dr. Marty Makary criticized the warnings as a "fear machine" deterring women from care.
Experts say updated research shows substantial benefits, especially when started before age 60.
The move aligns with rising U.S. legislative efforts to improve menopause care and remove barriers for millions.